These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 7428330)
21. An acute dose of desmethylimipramine inhibits brain uptake of [125I]3,3',5-triiodothyronine (T3) in thyroxine-induced but not T3-induced hyperthyroid rats: implications for tricyclic antidepressant therapy. Gordon JT; Tomlinson EE; Greenberg J; Dratman MB J Pharmacol Exp Ther; 1994 Jul; 270(1):111-7. PubMed ID: 8035306 [TBL] [Abstract][Full Text] [Related]
22. Stimulation of immediate early gene expression by desipramine in rat brain. Dahmen N; Fehr C; Reuss S; Hiemke C Biol Psychiatry; 1997 Sep; 42(5):317-23. PubMed ID: 9276071 [TBL] [Abstract][Full Text] [Related]
23. Desipramine antagonized corticosterone-induced apoptosis in cultured PC12 cells. Li YF; Luo ZP Acta Pharmacol Sin; 2002 Apr; 23(4):311-4. PubMed ID: 11931704 [TBL] [Abstract][Full Text] [Related]
24. An analysis of submandibular salivary gland function with desipramine and age in female NIA Fischer 344 rats. Koller MM; Cowman RA; Humphreys-Beher MG; Scarpace PJ Mech Ageing Dev; 2000 Nov; 119(3):131-47. PubMed ID: 11080533 [TBL] [Abstract][Full Text] [Related]
25. Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine. Kölzer M; Werth N; Sandhoff K FEBS Lett; 2004 Feb; 559(1-3):96-8. PubMed ID: 14960314 [TBL] [Abstract][Full Text] [Related]
26. The role of p-hydroxylation of amphetamine in its peripheral mode of action. Freeman JJ; Sulser F J Pharm Pharmacol; 1975 Jan; 27(1):38-42. PubMed ID: 235613 [TBL] [Abstract][Full Text] [Related]
27. Antidepressants and weight gain. Russ MJ; Ackerman SH Appetite; 1988 Apr; 10(2):103-17. PubMed ID: 3293530 [TBL] [Abstract][Full Text] [Related]
28. Central and peripheral contributions to the enhancement of amphetamine anorexia by desmethylimipramine (DMI). Towell A; Willner P; Booth DA Pharmacol Biochem Behav; 1985 Jan; 22(1):57-60. PubMed ID: 3975248 [TBL] [Abstract][Full Text] [Related]
29. [Characteristics of the adrenosensitizing action of tricyclic antidepressants]. Dolzhenko AT Farmakol Toksikol; 1974; 37(6):677-80. PubMed ID: 4464093 [No Abstract] [Full Text] [Related]
30. Nicotine and amphetamine: differential tolerance and no cross-tolerance for ingestive effects. Baettig K; Martin JR; Classen W Pharmacol Biochem Behav; 1980 Jan; 12(1):107-11. PubMed ID: 7367453 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of cellular atp-hydrolyzing activity by tricyclic antidepressants and phenothiazine tranquilizers. Medzihradsky F; Lin HL Life Sci; 1975 May; 16(9):1429-40. PubMed ID: 237168 [No Abstract] [Full Text] [Related]
32. The need for cautiously extrapolating results obtained with normal animals (healthy individuals) to depressed ones. Newman ME J Neurochem; 1998 Jun; 70(6):2641-2. PubMed ID: 9603232 [No Abstract] [Full Text] [Related]
33. [Effect of prolonged administration of amphetamine on the weight and macroscopic appearance of internal organs in rats]. Sośnierz M; Trzeciak H; Smigla K; Herman Z; Chruściel T Patol Pol; 1972; 23(3):395-9. PubMed ID: 5072531 [No Abstract] [Full Text] [Related]
34. Tricyclic antidepressant toxicity. Calesnick B Am Fam Physician; 1980 Jun; 21(6):104-6. PubMed ID: 7377080 [No Abstract] [Full Text] [Related]
35. Novel information about the influence of fluorination on activity in a series of tricyclic neuroleptic agents. Protiva M; Metysová J Act Nerv Super (Praha); 1978 Dec; 20(4):270-2. PubMed ID: 735730 [No Abstract] [Full Text] [Related]